USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2007 | 2006 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | -29.5 Thousand | - | - | -2.18 Million | -212.39 Thousand |
Net Income | - | -8.69 Million | -7160.00 | - | -11.12 Million | -658.3 Thousand |
Depreciation & Amortization | - | - | - | - | 256.76 Thousand | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -272.59 Thousand | - | - | -553.07 Thousand | 119.07 Thousand |
Other non-cash items | - | 9.2 Million | 7160.00 | - | 9.23 Million | 326.84 Thousand |
Investing Cash Flow | - | - | - | - | -1.08 Million | - |
Investments in PPE | - | - | - | - | -167.29 Thousand | - |
Acquisitions | - | - | - | - | -916.44 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | 31.05 Thousand | - | - | 3.37 Million | - |
Debt repayment | - | - | - | - | -1.89 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 2.27 Million | - |
Other Financing Activities | - | 31.05 Thousand | - | - | 1.09 Million | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | 6907.00 | - | - | -154.77 Thousand | - |
Inventory | - | -279.5 Thousand | - | - | -63.99 Thousand | - |
Other working capital | - | - | - | - | -334.31 Thousand | - |
Cash at beginning of period | 1546.00 | 1.00 | - | - | - | 212.39 Thousand |
Cash at end of period | 1546.00 | 1546.00 | - | - | 98.21 Thousand | - |
Capital Expenditure | - | - | - | - | -167.29 Thousand | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 1545.00 | - | - | 98.21 Thousand | -212.39 Thousand |
Free Cash Flow | - | -29.5 Thousand | - | - | -2.35 Million | -212.39 Thousand |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | 1546.00 | 2525.00 |
Cash at end of period | - | - | - | - | 1546.00 | 2525.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
VIVAA
ACE-R
KGN
DRAGARWQ
7072
0261